AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionMidwest Professional Planners, LTD.
Latest Disclosed Ownership10,897 shares
Latest Disclosed Value $ 2,369,975
Midwest Professional Planners, LTD. reports 38.07% decrease in ownership of 4AB / AbbVie Inc.

On May 5, 2026 - Midwest Professional Planners, LTD. filed a 13F-HR form disclosing ownership of 10,897 shares of AbbVie Inc. (BG:4AB) valued at $2,369,975 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 17,596 shares of AbbVie Inc.. This represents a change in shares of -38.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 10,897 -6,699 -38.07 2,370 -41.07 0.5583
2026-02-06 2025-12-31 13F ABBVIE COM 00287Y109 17,596 3,256 22.71 4,021 21.08 0.9524
2025-11-04 2025-09-30 13F ABBVIE COM 00287Y109 14,340 254 1.80 3,320 27.01 0.8101
2025-08-11 2025-06-30 13F ABBVIE COM 00287Y109 14,086 401 2.93 2,615 -8.82 0.6885
2025-05-02 2025-03-31 13F ABBVIE COM 00287Y109 13,685 90 0.66 2,867 18.72 0.8923
2025-02-10 2024-12-31 13F ABBVIE COM 00287Y109 13,595 499 3.81 2,416 -6.61 0.7214
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 13,096 758 6.14 2,586 22.21 0.7907
2024-08-06 2024-06-30 13F ABBVIE COM 00287Y109 12,338 -5,362 -30.29 2,116 -34.35 0.7072
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 17,700 1,227 7.45 3,223 26.29 1.1307
2024-02-15 2023-12-31 13F ABBVIE COM 00287Y109 16,473 -2,671 -13.95 2,553 -10.55 1.0176
2024-02-15 2023-12-31 13F ABBVIE COM 00287Y109 16,473 2,553
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 19,144 2,325 13.82 2,854 25.90 1.2833
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 16,819 2,295 15.80 2,266 -2.07 0.9926
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 14,524 1,016 7.52 2,315 6.00 1.1323
2023-02-10 2022-12-31 13F ABBVIE COM 00287Y109 13,508 1,031 8.26 2,183 30.33 1.2083
2022-11-10 2022-09-30 13F ABBVIE COM 00287Y109 12,477 874 7.53 1,675 -5.74 0.9994
2022-08-09 2022-06-30 13F ABBVIE COM 00287Y109 11,603 598 5.43 1,777 -0.39 1.0023
2022-05-11 2022-03-31 13F ABBVIE COM 00287Y109 11,005 623 6.00 1,784 26.88 0.8776
2022-02-10 2021-12-31 13F ABBVIE COM 00287Y109 10,382 215 2.11 1,406 28.17 0.6830
2021-11-08 2021-09-30 13F ABBVIE COM 00287Y109 10,167 266 2.69 1,097 -1.61 0.5818
2021-08-10 2021-06-30 13F ABBVIE COM 00287Y109 9,901 4,775 93.15 1,115 185.17 0.5809
2021-05-17 2021-03-31 13F AbbVie COM 00287Y109 5,126 -4,375 -46.05 391 -61.59 0.3861
2021-03-11 2020-12-31 13F ABBVIE COM 00287Y109 9,501 490 5.44 1,018 29.02 0.6272
2020-11-06 2020-09-30 13F AbbVie COM 00287Y109 9,011 816 9.96 789 -1.99 0.5550
2020-08-14 2020-06-30 13F AbbVie COM 00287Y109 8,195 3,069 59.87 805 105.88 0.6339
2020-05-05 2020-03-31 13F AbbVie COM 00287Y109 5,126 206 4.19 391 -10.32 0.3861
2020-02-11 2019-12-31 13F AbbVie COM 00287Y109 4,920 -24 -0.49 436 16.58 0.3561
2019-11-14 2019-09-30 13F AbbVie COM 00287Y109 4,944 1,961 65.74 374 72.35 0.3345
2019-08-12 2019-06-30 13F AbbVie COM 00287Y109 2,983 -70 -2.29 217 -11.79 0.2013
2019-05-08 2019-03-31 13F AbbVie COM 00287Y109 3,053 -6,182 -66.94 246 -71.09 0.2375
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 9,235 -58 -0.62 851 -3.19 0.9160
2018-11-13 2018-09-30 13F AbbVie COM 00287Y109 9,293 4,814 107.48 879 111.81 0.8071
2018-08-10 2018-06-30 13F AbbVie COM 00287Y109 4,479 64 1.45 415 -0.72 0.3711
2018-05-15 2018-03-31 13F AbbVie COM 00287Y109 4,415 305 7.42 418 5.29 0.3767
2018-02-12 2017-12-31 13F ABBVIE INC COM COM 00287Y109 4,110 4,110 397 0.3625
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.